Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001056520-12-000368
Filing Date
2012-08-14
Accepted
2012-08-14 16:56:20
Documents
9
Period of Report
2012-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q cellcyteform10qjune302012v3a.htm 10-Q 273797
2 CERTIFICATION exhibit31.htm EX-31 12347
3 CERTIFICATOIN exhibit32.htm EX-31 5027
  Complete submission text file 0001056520-12-000368.txt   1586603

Data Files

Seq Description Document Type Size
4 ccyg-20120630.xml EX-101.INS 197219
5 ccyg-20120630.xsd EX-101.SCH 7496
6 ccyg-20120630_cal.xml EX-101.CAL 4855
7 ccyg-20120630_def.xml EX-101.DEF 5672
8 ccyg-20120630_lab.xml EX-101.LAB 87958
9 ccyg-20120630_pre.xml EX-101.PRE 63110
Mailing Address PMB189 14205 SE 36TH, SUITE 100 BELLEVUE WA 98006
Business Address PMB189 14205 SE 36TH, SUITE 100 BELLEVUE WA 98006 425-519-3755
CELLCYTE GENETICS CORP (Filer) CIK: 0001325279 (see all company filings)

EIN.: 861127046 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-52238 | Film No.: 121033898
SIC: 2834 Pharmaceutical Preparations